| Summary of Net Revenue, Cost of Sales, Depreciation and Amortization, Operating Profit, and Interest Expense and Assets by Segment |
The following table shows, by segment: net revenue, cost of sales, depreciation and amortization, operating profit, and interest expense for the three months ended February 28, 2022 and 2021:
|
|
|
|
|
|
|
|
|
|
|
For the three months ended February 28, |
|
|
|
2022 |
|
|
2021 |
|
Net revenue: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
7,157,486 |
|
|
$ |
6,738,631 |
|
PrepaCyte CB |
|
|
18,200 |
|
|
|
38,000 |
|
Public cord blood banking |
|
|
82,845 |
|
|
|
83,986 |
|
Total net revenue |
|
$ |
7,258,531 |
|
|
$ |
6,860,617 |
|
Cost of sales: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
1,714,672 |
|
|
$ |
1,640,015 |
|
PrepaCyte CB |
|
|
30,658 |
|
|
|
34,880 |
|
Public cord blood banking |
|
|
357,872 |
|
|
|
337,302 |
|
Total cost of sales |
|
$ |
2,103,202 |
|
|
$ |
2,012,197 |
|
Operating profit: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
1,765,213 |
|
|
$ |
1,492,353 |
|
PrepaCyte CB |
|
|
(19,403 |
) |
|
|
(3,777 |
) |
Public cord blood banking |
|
|
(275,388 |
) |
|
|
(253,315 |
) |
Total operating profit |
|
$ |
1,470,422 |
|
|
$ |
1,235,261 |
|
Depreciation and amortization: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
270,862 |
|
|
$ |
14,368 |
|
PrepaCyte CB |
|
|
6,944 |
|
|
|
6,895 |
|
Public cord blood banking |
|
|
360 |
|
|
|
— |
|
Total depreciation and amortization |
|
$ |
278,166 |
|
|
$ |
21,263 |
|
Interest expense: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
306,095 |
|
|
$ |
280,219 |
|
PrepaCyte CB |
|
|
— |
|
|
|
— |
|
Public cord blood banking |
|
|
— |
|
|
|
— |
|
Total interest expense |
|
$ |
306,095 |
|
|
$ |
280,219 |
|
The following table shows the assets by segment as of February 28, 2022 and November 30, 2021:
|
|
|
|
|
|
|
|
|
|
|
As of |
|
|
As of |
|
|
|
February 28, 2022 |
|
|
November 30, 2021 |
|
Assets: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell
service |
|
$ |
44,302,449 |
|
|
$ |
50,170,887 |
|
PrepaCyte CB |
|
|
272,372 |
|
|
|
250,591 |
|
Public cord blood banking |
|
|
10,233,477 |
|
|
|
10,240,598 |
|
Total assets |
|
$ |
54,808,298 |
|
|
$ |
60,662,076 |
|
|